Literature DB >> 19892016

Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation.

Nabanita S Datta1, Rola Kolailat, Alemu Fite, Glenda Pettway, Abdul B Abou-Samra.   

Abstract

Parathyroid hormone (PTH) and PTH-related protein (PTHrP) activate one single receptor (PTH1R) which mediates catabolic and anabolic actions in the bone. Activation of PTH1R modulates multiple intracellular signaling responses. We previously reported that PTH and PTHrP down-regulate pERK1/2 and cyclin D1 in differentiated osteoblasts. In this study we investigate the role of MAPK phosphatase-1 (MKP-1) in PTHrP regulation of ERK1/2 activity in relation to osteoblast proliferation, differentiation and bone formation. Here we show that PTHrP increases MKP-1 expression in differentiated osteoblastic MC3T3-E1 cells, primary cultures of differentiated bone marrow stromal cells (BMSCs) and calvarial osteoblasts. PTHrP had no effect on MKP-1 expression in proliferating osteoblastic cells. Overexpression of MKP-1 in MC-4 cells inhibited osteoblastic cell proliferation. Cell extracts from differentiated MC-4 cells treated with PTHrP inactivate/dephosphorylate pERK1/2 in vitro; immunodepletion of MKP-1 blocked the ability of the extract to dephosphorylate pERK1/2; these data indicate that MKP-1 is involved in PTHrP-induced pERK1/2 dephosphorylation in the differentiated osteoblastic cells. PTHrP regulation of MKP-1 expression is partially dependent on PKA and PKC pathways. Treatment of nude mice, bearing ectopic ossicles, with intermittent PTH for 3weeks, up-regulated MKP-1 and osteocalcin, a bone formation marker, with an increase in bone formation. These data indicate that PTH and PTHrP increase MKP-1 expression in differentiated osteoblasts; and that MKP-1 induces growth arrest of osteoblasts, via inactivating pERK1/2 and down-regulating cyclin D1; and identify MKP-1 as a possible mediator of the anabolic actions of PTH1R in mature osteoblasts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19892016      PMCID: PMC2795117          DOI: 10.1016/j.cellsig.2009.10.017

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  52 in total

Review 1.  New insights into the control of MAP kinase pathways.

Authors:  J English; G Pearson; J Wilsbacher; J Swantek; M Karandikar; S Xu; M H Cobb
Journal:  Exp Cell Res       Date:  1999-11-25       Impact factor: 3.905

2.  Evidences for a role of p38 MAP kinase in the stimulation of alkaline phosphatase and matrix mineralization induced by parathyroid hormone in osteoblastic cells.

Authors:  A Rey; D Manen; R Rizzoli; S L Ferrari; J Caverzasio
Journal:  Bone       Date:  2007-03-14       Impact factor: 4.398

3.  MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1.

Authors:  G Xiao; D Jiang; P Thomas; M D Benson; K Guan; G Karsenty; R T Franceschi
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

Review 4.  Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone.

Authors:  David Goltzman
Journal:  Arch Biochem Biophys       Date:  2008-03-10       Impact factor: 4.013

5.  Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation.

Authors:  Glenda J Pettway; Jeffrey A Meganck; Amy J Koh; Evan T Keller; Steven A Goldstein; Laurie K McCauley
Journal:  Bone       Date:  2007-12-15       Impact factor: 4.398

6.  Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.

Authors:  Diane Gesty-Palmer; Minyong Chen; Eric Reiter; Seungkirl Ahn; Christopher D Nelson; Shuntai Wang; Allen E Eckhardt; Conrad L Cowan; Robert F Spurney; Louis M Luttrell; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2006-02-21       Impact factor: 5.157

7.  HMGB1 is a bone-active cytokine.

Authors:  Jieping Yang; Rita Shah; Alexander G Robling; Evan Templeton; Huan Yang; Kevin J Tracey; Joseph P Bidwell
Journal:  J Cell Physiol       Date:  2008-03       Impact factor: 6.384

8.  Atherogenic phospholipids attenuate osteogenic signaling by BMP-2 and parathyroid hormone in osteoblasts.

Authors:  Michael S Huang; Sean Morony; Jinxiu Lu; Zina Zhang; Olga Bezouglaia; Wendy Tseng; Sotirios Tetradis; Linda L Demer; Yin Tintut
Journal:  J Biol Chem       Date:  2007-05-22       Impact factor: 5.157

Review 9.  PTH and PTHrP signaling in osteoblasts.

Authors:  Nabanita S Datta; Abdul B Abou-Samra
Journal:  Cell Signal       Date:  2009-02-26       Impact factor: 4.315

10.  Interleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actions.

Authors:  Liza J Raggatt; Ling Qin; Joseph Tamasi; Stephen C Jefcoat; Emi Shimizu; Nagarajan Selvamurugan; Foo Y Liew; Laura Bevelock; Jean H M Feyen; Nicola C Partridge
Journal:  J Biol Chem       Date:  2007-12-28       Impact factor: 5.157

View more
  21 in total

1.  Role of PTH1R internalization in osteoblasts and bone mass using a phosphorylation-deficient knock-in mouse model.

Authors:  Nabanita S Datta; Tareq A Samra; Chandrika D Mahalingam; Tanuka Datta; Abdul B Abou-Samra
Journal:  J Endocrinol       Date:  2010-10-07       Impact factor: 4.286

Review 2.  Catabolic and anabolic actions of parathyroid hormone on the skeleton.

Authors:  B C Silva; A G Costa; N E Cusano; S Kousteni; J P Bilezikian
Journal:  J Endocrinol Invest       Date:  2011-09-23       Impact factor: 4.256

Review 3.  Minireview: Role of intracellular scaffolding proteins in the regulation of endocrine G protein-coupled receptor signaling.

Authors:  Cornelia Walther; Stephen S G Ferguson
Journal:  Mol Endocrinol       Date:  2015-05-05

4.  Transcriptomics analysis of early embryonic stem cell differentiation under osteoblast culture conditions: Applications for detection of developmental toxicity.

Authors:  Xinrong Chen; Tao Han; J Edward Fisher; Wafa Harrouk; Melissa S Tassinari; Gwenn E Merry; Daniel Sloper; James C Fuscoe; Deborah K Hansen; Amy L Inselman
Journal:  Reprod Toxicol       Date:  2017-02-08       Impact factor: 3.143

5.  Osteoporotic fracture and parathyroid hormone.

Authors:  Nabanita S Datta
Journal:  World J Orthop       Date:  2011-08-18

6.  MicroRNA-335-5p and -3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance.

Authors:  Elizabeth C Martin; Adrienne K Conger; Thomas J Yan; Van T Hoang; David F B Miller; Aaron Buechlein; Douglas B Rusch; Kenneth P Nephew; Bridgette M Collins-Burow; Matthew E Burow
Journal:  FEBS Lett       Date:  2017-01-12       Impact factor: 4.124

7.  Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.

Authors:  Chandrika D Mahalingam; Tanuka Datta; Rashmi V Patil; Jaclynn Kreider; R Daniel Bonfil; Keith L Kirkwood; Steven A Goldstein; Abdul B Abou-Samra; Nabanita S Datta
Journal:  J Endocrinol       Date:  2011-08-18       Impact factor: 4.286

Review 8.  Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism.

Authors:  Christian Santa Maria; Zhiqiang Cheng; Alfred Li; Jiali Wang; Dolores Shoback; Chia-Ling Tu; Wenhan Chang
Journal:  Semin Cell Dev Biol       Date:  2015-12-10       Impact factor: 7.727

Review 9.  Muscle-bone and fat-bone interactions in regulating bone mass: do PTH and PTHrP play any role?

Authors:  Nabanita S Datta
Journal:  Endocrine       Date:  2014-05-07       Impact factor: 3.633

10.  Functional roles of the nuclear localization signal of parathyroid hormone-related protein (PTHrP) in osteoblastic cells.

Authors:  A García-Martín; J A Ardura; M Maycas; D Lozano; A López-Herradón; S Portal-Núñez; A García-Ocaña; P Esbrit
Journal:  Mol Endocrinol       Date:  2014-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.